000 01285 a2200373 4500
005 20250517084635.0
264 0 _c20180101
008 201801s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0000000000002594
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCao, Yonghao
245 0 0 _aCNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.
_h[electronic resource]
260 _bNeurology
_c04 2016
300 _a1553-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aDemyelinating Diseases
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIpilimumab
_xadverse effects
700 1 _aNylander, Alyssa
700 1 _aRamanan, Sriram
700 1 _aGoods, Brittany A
700 1 _aPonath, Gerald
700 1 _aZabad, Rana
700 1 _aChiang, Veronica L S
700 1 _aVortmeyer, Alexander O
700 1 _aHafler, David A
700 1 _aPitt, David
773 0 _tNeurology
_gvol. 86
_gno. 16
_gp. 1553-6
856 4 0 _uhttps://doi.org/10.1212/WNL.0000000000002594
_zAvailable from publisher's website
999 _c25835174
_d25835174